You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

genetically modified lymphocytes

Showing 1 - 25 of 7,113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

Active, not recruiting
  • Acute Lymphocytic Leukemia
  • Lymphoma
  • Biological/Genetically Modified T cells
  • Cyclophosphamide-based chemotherapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Cervical Cancer, Ovarian Cancer, Malignant Trophoblastic Tumor Trial (Toripalimab + ScTIL)

Not yet recruiting
  • Cervical Cancer
  • +2 more
  • Toripalimab + ScTIL
  • (no location specified)
Apr 17, 2022

Advanced Tumor of Digestive Tract or Urinary System Trial in Beijing (ScTIL injection)

Not yet recruiting
  • Advanced Tumor of Digestive Tract or Urinary System
  • ScTIL injection
  • Beijing, China
    Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Aug 11, 2022

Relapsed B-Cell Acute Lymphoblastic Leukemia Trial in Boston, New York (procedure, drug, biological)

Active, not recruiting
  • Relapsed B-Cell Acute Lymphoblastic Leukemia
  • leukapheresis or collection of PBMCs
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 26, 2022

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +7 more
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 15, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
Has Results
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +2 more
  • Biopsy
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Buffalo

Active, not recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Aldesleukin
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 3, 2022

High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

Not yet recruiting
  • High Grade B-Cell Non-Hodgkin's Lymphoma
  • +3 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

Not yet recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +6 more
  • Axicabtagene Ciloleucel
  • +10 more
  • (no location specified)
Jan 13, 2023

Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

Recruiting
  • Adenovirus Infection
  • +6 more
  • Virus-specific Cytotoxic T-lymphocytes
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2023

After Adoptive Transfer of Genetically Modified Cell Products

Recruiting
  • Relapsed Hematologic Malignancy
  • Refractory Hematologic Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 6, 2023

    ß-thalassemia Trial (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • (no location specified)
    Mar 15, 2023

    ß-thalassemia Trial in Shanghai (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • Shanghai, China
      Shanghai Ruijin Hospital
    Mar 16, 2023

    Survival of Genetically Modified White Blood Cells in

    Active, not recruiting
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jan 3, 2023

      Solid Tumors Trial in New York (procedure, drug, device, genetic)

      Active, not recruiting
      • Solid Tumors
      • Production of Genetically-modified T cells
      • +4 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Sep 1, 2022

      Digestive System Malignant Solid Tumors Trial (ScTIL injection, ScTIL injection and B lymphocytes adjuvant)

      Not yet recruiting
      • Digestive System Malignant Solid Tumors
      • ScTIL injection
      • ScTIL injection and B lymphocytes adjuvant
      • (no location specified)
      Feb 7, 2023

      Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

      Active, not recruiting
      • Leukemia
      • Acute Lymphoblastic Leukemia
      • gene-modified T cells targeted
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Feb 1, 2023

      Junctional Epidermolysis Bullosa Non-Herlitz Type Trial in Paris, Modena (Transplantation)

      Recruiting
      • Junctional Epidermolysis Bullosa Non-Herlitz Type
      • Paris, France
      • +1 more
      Aug 8, 2022

      Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified

      Not yet recruiting
      • Glioblastoma
      • Autologous genetically modified gamma-delta T cells
      • Allogeneic genetically modified gamma-delta T cells
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Dec 16, 2022

      Junctional Epidermolysis Bullosa Trial in Salzburg (Transplantation surgery of genetically corrected cultured epidermal

      Terminated
      • Junctional Epidermolysis Bullosa
      • Transplantation surgery of genetically corrected cultured epidermal autograft (ATMP)
      • Salzburg, Austria
        EB House Austria, Department of Dermatology, Paracelsus Medical
      Feb 18, 2022